ArticleScientific reports2026
Dual branch fundus deep learning network as an enhanced multi classification system for ocular disease detection via hybrid feature fusion.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ophthalmic diagnosis relies heavily on the interpretation of fundus images to identify a range of debilitating diseases. However, the presence of multiple, co-existing pathologies and the subtle visual cues associated with early-stage disease pose a significant challenge, necessitating the development of advanced diagnostic tools. We present DFD-Net (Dual-Branch Fundus Deep Learning Network), a deep learning solution that performs multi-label classification of various ocular diseases. The system achieves this by integrating the attribute maps from bilateral retinal photographs, like those from the right and left eyes. This study starts with a thorough pre-processing operation on the fundus images, represented in image rescaling, black border image cropping, contrast enhancement, and data augmentation of retinal photographs. Following this, the processing pipeline begins with a dual-branch feature extraction framework. A part of the system employs a ConvNeXt architecture to obtain complex semantic characteristics, while the parallel branch employs a U-Net encoder to capture fine-grained, structural characteristics across several scales. These complementary feature representations are then combined via a fusion mechanism. The fused feature representations are subsequently enhanced by a SENet Block for greater robustness through channel-wise recalibration. The resulting feature maps are reduced via Global Average Pooling, and then passed through a Dense layer for feature refinement. Finally, the features are classified by a Softmax output layer, consistent with the single-label multi-class formulation adopted in this work, to identify one of eight possible categories. The testing was implemented on the Ocular Disease Intelligent Recognition-Ophthalmic Image analysis (OIA-ODIR) dataset, which has retinal photographs that represent six distinct ophthalmic categories, macular degeneration, cataracts, glaucoma, hypertension, diabetic retinopathy, and myopia, images that present normal cases, and images that represent multiple other diseases, depicting eight different categories. The proposed DFD-Net system established precision, recall, F1- scores, and overall accuracy of 92.75%, 93.17%, 94.45%, and 93.77% on the On-Site testing collection and 91.50%, 93.19%, 92.11%, and 92.97% on the Off-Site testing collection, respectively. Ultimately, the suggested DFD-Net system proved high efficiency in precisely classifying multiple ocular diseases, offering a novel and outstanding approach for early detection of fundus diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.